T. Tamura

Cooperative Role of the Membrane-proximal and -distal Residues of the Integrin β3 Cytoplasmic Domain in Regulation of Talin-mediated αIIbβ3 Activation*

M. Yasukawa, J. Yamanouchi, T. Hato, 2008, Journal of Biological Chemistry.

Existence of Leukemic Clones Resistant to Both Imatinib Mesylate and Rituximab before Drug Therapies in a Patient with Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

S. Fujita, M. Yasukawa, J. Yamanouchi, 2004, International journal of hematology.

Critical residues for ligand binding in blade 2 of the propeller domain of the integrin αIIb subunit

S. Fujita, J. Yamanouchi, T. Hato, 2003, Thrombosis and Haemostasis.

Suppression of integrin activation by the membrane-distal sequence of the integrin alphaIIb cytoplasmic tail.

S. Fujita, J. Yamanouchi, T. Hato, 2004, The Biochemical journal.

Novel RUNX1‐PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22)

S. Fujita, M. Yasukawa, T. Hato, 2005, Genes, chromosomes & cancer.

Identification of Critical Residues for Ligand Binding in the Integrin β3 I-domain by Site-directed Mutagenesis

S. Fujita, J. Yamanouchi, T. Hato, 2002, Thrombosis and Haemostasis.

Identification of an epitope on glycoprotein IIb‐IIIa that is recognized by HLA‐DRB1*0405‐restricted CD4+‘superior’ T cells from a patient with immune thrombocytopenic purpura

M. Yasukawa, J. Yamanouchi, T. Hato, 2004, Journal of thrombosis and haemostasis : JTH.

Compound heterozygous mutations in the PROS1 gene responsible for quantitative and qualitative protein S deficiency

H. Fujiwara, M. Yasukawa, J. Yamanouchi, 2009, International journal of hematology.